New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study-Reference-Cited by-同舟云学术

New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study

Published:2018-01-24 Issue:2 Volume:41 Page:143-154
ISSN:0147-8389
Container-title:Pacing and Clinical Electrophysiology
language:en
Short-container-title:Pacing Clin Electrophysiol

Author:

Wang Norman C.¹^ORCID,Li Jack Z.¹,Adelstein Evan C.¹,Althouse Andrew D.¹,Sharbaugh Michael S.¹,Jain Sandeep K.¹,Mendenhall G. Stuart¹,Shalaby Alaa A.¹,Voigt Andrew H.¹,Saba Samir¹

Affiliation:

1. Heart and Vascular Institute; University of Pittsburgh Medical Center; Pittsburgh PA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pace.13264/fullpdf

Reference43 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J Am Coll Cardiol,2013

2. Cardiac resynchronization therapy in women versus men: Observational comparative effectiveness study from the National Cardiovascular Data Registry;Zusterzeel;Circ Cardiovasc Qual Outcomes,2015

3. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials;Kusumoto;J Am Coll Cardiol,2014